Table 3.

Incidence of condyloma^a by HPV type detected in the lesion among men^b with the same HPV type detected at the genitals in the HIM Study

HPV Typede	Incidence Ratec (95% CI)	Cumulative Incidence (%)
		6-Month (95% CI)	12-Month (95% CI)	24-Month (95% CI)
Any	1.1 (0.9–1.3)	0.7 (0.4–0.9)	1.7 (1.3–2.1)	2.7 (2.1–3.3)
Vaccinef	4.7 (3.7–5.8)	2.9 (1.8–4.0)	7.3 (5.4–9.1)	11.1 (8.7–13.6)
High Risk	0.3 (0.2–0.5)	0.2 (0.0–0.3)	0.6 (0.2–0.9)	0.8 (0.4–1.3)
16	0.5 (0.1–1.3)	0.0 (0.0–0.0)	0.9 (0.3–2.8)	1.3 (0.5–3.6)
18	0.3 (0.0–1.7)	0.7 (0.1–4.9)	0.7 (0.1–4.9)	0.7 (0.1–4.9)
31	0.4 (0.0–2.3)	0.9 (0.1–6.2)	0.9 (0.1–6.2)	0.9 (0.1–6.2)
39	0.2 (0.0–1.2)	0.5 (0.1–3.2)	0.5 (0.1–3.2)	0.5 (0.1–3.2)
45	0.3 (0.0–1.9)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	1.7 (0.2–11.6)
51	0.2 (0.0–0.9)	0.0 (0.0–0.0)	0.3 (0.0–2.3)	0.8 (0.2–3.2)
52	0.6 (0.2–1.6)	0.0 (0.0–0.0)	1.2 (0.4–3.7)	1.2 (0.4–3.7)
56	0.4 (0.0–2.0)	0.9 (0.1–6.1)	0.9 (0.1–6.1)	0.9 (0.1–6.1)
Low Risk	2.1 (1.7–2.6)	1.3 (0.8–1.8)	3.3 (2.4–4.2)	5.3 (4.1–6.4)
6	12.7 (9.6–16.3)	5.9 (3.5–9.7)	16.4 (12.1–22.1)	26.6 (20.8–33.6)
11	13.1 (7.7–21.0)	12.3 (6.6–22.4)	21.9 (13.8–33.9)	26.7 (17.2–40.0)
40	0.4 (0.0–2.3)	0.0 (0.0–0.0)	1.0 (0.1–7.0)	1.0 (0.1–7.0)
53	0.3 (0.0–0.9)	0.3 (0.0–2.0)	0.3 (0.0–2.0)	0.8 (0.2–3.5)
54	0.2 (0.0–1.1)	0.0 (0.0–0.0)	0.6 (0.1–4.1)	0.6 (0.1–4.1)
66	0.4 (0.1–1.1)	0.0 (0.0–0.0)	0.3 (0.0–2.4)	1.2 (0.4–3.8)

Abbreviation: CI-confidence interval.

^aDNA detected using Linear Array.

^bNewly acquired, pathologically confirmed condyloma/suggestive of condyloma.

^cIncidence rate is cases per 1000 person-months.

^dPrevalent and incident genital HPV infections.

^eHPV types 33/35/58/59/26/68/69/71/70/73/82 did not progress to a condyloma lesion; therefore, incidence rates and cumulative incidence could not be calculated.

^fVaccine HPV types 6/11/16/18